Top Clinical Trials companies in Poland by Free Cash Flow Per Share
Poland
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 0.07
|
Dec. 31, 2023 | USD 10.82 | 1.26% |
|
Poland |
|
| 2 |
USD -0.39
|
Dec. 31, 2023 | USD 1.87 | 0.85% |
|
Poland |
|
| 3 |
USD -0.85
|
Dec. 31, 2023 | USD 2.20 | -0.33% |
|
Poland |
|
| 4 |
USD -0.98
|
Dec. 31, 2023 | USD 6.89 | -1.14% |
|
Poland |
|
| 5 |
USD -2.44
|
Dec. 31, 2023 | USD 9.62 | -0.82% |
|
Poland |
|
| 6 |
USD -3.01
|
Dec. 31, 2023 | USD 12.56 | 1.66% |
|
Poland |
Frequently Asked Questions
-
Which Clinical Trials company in Poland has the highest Free Cash Flow Per Share ?
The Clinical Trials company in Poland with the highest Free Cash Flow Per Share is Selvita S.A. (Warsaw Stock Exchange: SLV.WA) at USD 0.07.
-
Which Clinical Trials company in Poland has the lowest Free Cash Flow Per Share ?
The Clinical Trials company in Poland with the lowest Free Cash Flow Per Share is Captor Therapeutics Spolka Akcyjna (Warsaw Stock Exchange: CTX.WA) at USD -3.01.
-
What are the top 10 Clinical Trials companies in Poland by Free Cash Flow Per Share ?
The top 10 Clinical Trials companies in Poland by Free Cash Flow Per Share are Selvita S.A., Medinice S.A., Molecure S.A., Ryvu Therapeutics S.A., Poltreg S.A. and Captor Therapeutics Spolka Akcyjna.
-
What are the bottom 10 Clinical Trials companies in Poland by Free Cash Flow Per Share ?
The bottom 10 Clinical Trials companies in Poland by Free Cash Flow Per Share are Captor Therapeutics Spolka Akcyjna, Poltreg S.A., Ryvu Therapeutics S.A., Molecure S.A., Medinice S.A. and Selvita S.A..
